Leukocyte Telomere Length Independently Predicts Hyperuricemia Risk in a Longitudinal Study of the Chinese Population

Mengya Qi,Jie Yu,Fan Ping,Lingling Xu,Wei Li,Huabing Zhang,Yuxiu Li
DOI: https://doi.org/10.1016/j.numecd.2023.10.004
IF: 4.666
2023-10-12
Nutrition Metabolism and Cardiovascular Diseases
Abstract:Background and Aims Leukocyte telomere length (LTL) has been correlated with uric acid levels, although results are inconsistent, and prospective studies are lacking. In this longitudinal, prospective cohort study, we aimed to assess whether a shorter LTL predicts the risk of hyperuricemia. Methods and Results We conducted a longitudinal study in a Chinese cohort of 599 participants. Of these, 266 participants completed a 5.9-year follow-up from June 2014 to December 2021. LTL was assessed at baseline using real-time polymerase chain reaction. Hyperuricemia was defined as serum uric acid ≥ 420 mmol/L according to Chinese guidelines for diagnosis and treatment of hyperuricemia and gout. Participants who had developed hyperuricemia during follow-up (n = 17) had shorter LTL at baseline. Baseline LTL was independently associated with the development of hyperuricemia at follow-up after adjusting for conventional hyperuricemia risk factors (odds ratio [OR] 2.347 [95% confidence interval [CI] 1.123, 4.906]; P = 0.023). After grouping according to LTL tertiles, the incidence of hyperuricemia was 18.334-fold higher for the first than for the third tertile (OR 18.334 [95%CI 1.786, 191.272]; P = 0.014, P for trend = 0.050). Conclusion Our findings in a prospective cohort suggest that LTL could predict hyperuricemia risk, which might inform the timely prevention and treatment of hyperuricemia.
cardiac & cardiovascular systems,endocrinology & metabolism,nutrition & dietetics
What problem does this paper attempt to address?